Summit Therapeutics (SMMT) EPS (Basic) (2017 - 2024)
Summit Therapeutics' (SMMT) quarterly EPS (Basic) came in at -$0.1 in Q4 2024, down 60.8% YoY from -$0.26 in Q1 2024, and down 21.22% on a QoQ basis from -$0.08 in Q3 2024.
Summit Therapeutics (SMMT) EPS (Basic) (2017 - 2024) Analysis & Trends
Summit Therapeutics (SMMT) has 8 years of EPS (Basic) data on file, last reported at -$0.1 in Q4 2024.
- Quarterly EPS (Basic) fell 60.8% year-over-year to -$0.1 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$0.1 (up 65.76% YoY) and the FY2024 annual result came in at -$2.65, down 166.98% from the prior year.
- EPS (Basic) eased to -$0.1 in Q4 2024, from -$0.08 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.03 in Q2 2023 to a low of -$1.44 in Q1 2023.
- A 5-year average of -$0.21 and a median of -$0.13 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) slumped 528.86% — and 2024, when it soared 95.5%.
- Tracing SMMT's EPS (Basic) over 5 years: stood at -$0.19 in 2020, then plunged by 50.84% to -$0.29 in 2021, then jumped by 59.15% to -$0.12 in 2022, then surged by 47.41% to -$0.06 in 2023, then plunged by 60.8% to -$0.1 in 2024.
- The last three EPS (Basic) figures came in at -$0.1 (Q4 2024), -$0.08 (Q3 2024), and -$0.09 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -1.44 |
| Dec 31, 2022 | -0.12 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.13 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.29 |
| Sep 30, 2021 | -0.20 |
| Jun 30, 2021 | -0.27 |
| Mar 31, 2021 | -0.21 |
| Dec 31, 2020 | -0.19 |
| Sep 30, 2020 | -0.26 |
| Jun 30, 2020 | -0.23 |
| Mar 31, 2020 | -0.09 |